Younossi Y - Search Results

1

Adherence to treatment of chronic hepatitis C: from interferon containing regimens to interferon and ribavirin free regimens.

Younossi ZM, Stepanova M, Henry L, Nader F, Younossi Y, Hunt S. Younossi ZM, et al. Among authors: younossi y. Medicine (Baltimore). 2016 Jul;95(28):e4151. doi: 10.1097/MD.0000000000004151. Medicine (Baltimore). 2016. PMID: 27428205 Free PMC article.

2

Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.

Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, Srishord M. Younossi ZM, et al. Among authors: younossi y. Clin Gastroenterol Hepatol. 2011 Jun;9(6):524-530.e1; quiz e60. doi: 10.1016/j.cgh.2011.03.020. Epub 2011 Mar 25. Clin Gastroenterol Hepatol. 2011. PMID: 21440669

3

Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity.

Stepanova M, Lam B, Younossi Y, Srishord MK, Younossi ZM. Stepanova M, et al. Among authors: younossi zm, younossi y. J Viral Hepat. 2012 May;19(5):341-5. doi: 10.1111/j.1365-2893.2011.01554.x. Epub 2011 Nov 9. J Viral Hepat. 2012. PMID: 22497813

4

Nonalcoholic fatty liver disease in lean individuals in the United States.

Younossi ZM, Stepanova M, Negro F, Hallaji S, Younossi Y, Lam B, Srishord M. Younossi ZM, et al. Among authors: younossi y. Medicine (Baltimore). 2012 Nov;91(6):319-327. doi: 10.1097/MD.0b013e3182779d49. Medicine (Baltimore). 2012. PMID: 23117851

5

In an era of highly effective treatment, hepatitis C screening of the United States general population should be considered.

Younossi Z, Blissett D, Blissett R, Henry L, Younossi Y, Beckerman R, Hunt S. Younossi Z, et al. Among authors: younossi y. Liver Int. 2018 Feb;38(2):258-265. doi: 10.1111/liv.13519. Epub 2017 Aug 24. Liver Int. 2018. PMID: 28719013

6

Epidemiology of chronic liver diseases in the USA in the past three decades.

Younossi ZM, Stepanova M, Younossi Y, Golabi P, Mishra A, Rafiq N, Henry L. Younossi ZM, et al. Among authors: younossi y. Gut. 2020 Mar;69(3):564-568. doi: 10.1136/gutjnl-2019-318813. Epub 2019 Jul 31. Gut. 2020. PMID: 31366455

7

Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD.

Paik JM, Golabi P, Younossi Y, Mishra A, Younossi ZM. Paik JM, et al. Among authors: younossi y. Hepatology. 2020 Nov;72(5):1605-1616. doi: 10.1002/hep.31173. Epub 2020 Oct 27. Hepatology. 2020. PMID: 32043613

8

The Growing Burden of Disability Related to Nonalcoholic Fatty Liver Disease: Data From the Global Burden of Disease 2007-2017.

Paik JM, Golabi P, Younossi Y, Srishord M, Mishra A, Younossi ZM. Paik JM, et al. Among authors: younossi y. Hepatol Commun. 2020 Sep 14;4(12):1769-1780. doi: 10.1002/hep4.1599. eCollection 2020 Dec. Hepatol Commun. 2020. PMID: 33305148 Free PMC article.

9

Recent Trends in the Global Burden of Hepatitis B Virus: 2007-2017.

Paik JM, Younossi Y, Henry L, Mishra A, Younossi ZM. Paik JM, et al. Among authors: younossi y. Gastroenterology. 2021 Apr;160(5):1845-1846.e3. doi: 10.1053/j.gastro.2020.11.057. Epub 2021 Jan 6. Gastroenterology. 2021. PMID: 33421516 No abstract available.

10

The Growing Burden of Disability Related to Chronic Liver Disease in the United States: Data From the Global Burden of Disease Study 2007-2017.

Paik JM, Golabi P, Younossi Y, Saleh N, Nhyira A, Younossi ZM. Paik JM, et al. Among authors: younossi y. Hepatol Commun. 2021 Jan 14;5(5):749-759. doi: 10.1002/hep4.1673. eCollection 2021 May. Hepatol Commun. 2021. PMID: 34027266 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results